Details for Patent: 10,639,375
✉ Email this page to a colleague
Which drugs does patent 10,639,375 protect, and when does it expire?
Patent 10,639,375 protects BIJUVA and is included in one NDA.
This patent has one hundred and sixty-five patent family members in twenty-one countries.
Summary for Patent: 10,639,375
| Title: | Progesterone formulations |
| Abstract: | Various pharmaceutical formulations are disclosed herein. For example, a pharmaceutical formulation is disclosed comprising ultra-micronized progesterone. |
| Inventor(s): | Brian A. Bernick, Julia M. Amadio, Peter H. R. Persicaner, Janice Louise Cacace, Thorsteinn Thorsteinsson, Frederick D. Sancilio, Neda Irani |
| Assignee: | TherapeuticsMD Inc |
| Application Number: | US16/037,452 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 10,639,375 |
|
Patent Claim Types: see list of patent claims | Composition; Dosage form; |
Drugs Protected by US Patent 10,639,375
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mayne Pharma | BIJUVA | estradiol; progesterone | CAPSULE;ORAL | 210132-001 | Oct 28, 2018 | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | Y | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 10,639,375
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| European Patent Office | 2782584 | ⤷ Start Trial | 301153 | Netherlands | ⤷ Start Trial |
| European Patent Office | 2782584 | ⤷ Start Trial | 2021C/558 | Belgium | ⤷ Start Trial |
| European Patent Office | 2782584 | ⤷ Start Trial | 122021000080 | Germany | ⤷ Start Trial |
| European Patent Office | 2782584 | ⤷ Start Trial | LUC00245 | Luxembourg | ⤷ Start Trial |
| European Patent Office | 2782584 | ⤷ Start Trial | 132021000000197 | Italy | ⤷ Start Trial |
| European Patent Office | 2782584 | ⤷ Start Trial | C202130068 | Spain | ⤷ Start Trial |
| European Patent Office | 2782584 | ⤷ Start Trial | 21C1058 | France | ⤷ Start Trial |
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
